Ncardia is a stem cell drug discovery and development company. The Company is focused on the development of fully functional human assay systems for use in drug discovery and development. Ncardia's goal is to be the supportive and trusted partner for scientists operating in the hiPSC drug discovery and development space including cardiovascular and neural safety and efficacy studies.
|Employees (est.) (Feb 2021)||52||(+2%)|
Ncardia total Funding
Ncardia latest funding size
Time since last funding
|3 years ago|
|S.R.I.W., Vesalius Biocapital Partners, InnovationQuarter, SFPI-FPIM, Sambrinvest, Epimède SA|
Ncardia has 897 Twitter Followers. The number of followers has increased 0.3% month over month and increased 0.1% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Ncardia founded?
Ncardia was founded in 2010.
Who are Ncardia key executives?
Ncardia's key executives are Stefan Braam, Alain Parthoens and Johan Te Koppele.
How many employees does Ncardia have?
Ncardia has 52 employees.
Who are Ncardia competitors?
Competitors of Ncardia include Hepion Pharmaceuticals, Rigel Pharmaceuticals and Bristol-Myers Squibb.
Where is Ncardia headquarters?
Ncardia headquarters is located at 47 Rue Adrienne Bolland, Gosselies.
Where are Ncardia offices?
Ncardia has offices in Gosselies and Leiden.
How many offices does Ncardia have?
Ncardia has 2 offices.
Receive alerts for 300+ data fields across thousands of companies